Showing results (251-260 of 354) with videos related to
Sort By:
Pageof 36
Cancer Research|October 1, 1981
Immunobiological properties of 1-butanol-extracted cell surface antigensS J LeGrue, J P Allison, C M Macek, et al.Cancer|December 1, 1975
Purification of tumor-specific antigens. An overview of the relevance to human colon carcinomaB D Kahan, B H Tom, M B Mokyr, et al.Transplantation|December 1, 1984
The use of cyclosporine in living-related renal transplantation. Donor-specific hyporesponsiveness and steroid withdrawalS M Flechner, R H Kerman, C T Van Buren, et al.Surgery|August 1, 1982
The cellular target of cyclosporin A action in humansC T Van Buren, R Kerman, G Agostino, et al.Neurosurgery|August 1, 1979
Kidney donation: needs and possibilitiesH H Kaufman, J D Huchton, M M McBride, et al.Transplantation|June 8, 2001
RAD in de novo renal transplantation: comparison of three doses on the incidence and severity of acute rejectionB D Kahan, B Kaplan, M I Lorber, et al.Transplantation|July 1, 1981
Correlation of nonspecific immune monitoring with rejection or impaired function of renal allograftsR H Kerman, M Floyd, C Van Buren, et al.Transplantation Proceedings|April 26, 2005
Rabbit antithymocyte globulin: a postoperative risk factor for sirolimus-treated renal transplant patients?C Benavides, K H Mahmoud, R Knight, et al.Transplantation|February 1, 1989
Improved immunosuppression for heart transplant patients using intravenous doses of cyclosporineM P Macris, O H Frazier, C T Van Buren, et al.Transplantation|December 1, 1985
Successful transplantation of cyclosporine-treated allograft recipients with serologically positive historical, but negative preoperative, donor crossmatchesR H Kerman, S M Flechner, C T Van Buren, et al.Pageof 36